SEC Filings
Praxis Plans Epilepsy Drug Launch With A Proposed Annual List Price Of Up To $600,000
The company also proposed $50,000–$100,000 a year for its essential-tremor drug as both treatments await FDA decisions.
SEC Filings
The company also proposed $50,000–$100,000 a year for its essential-tremor drug as both treatments await FDA decisions.
SEC Filings
Cloud customer commitments exceed $14 billion, while management expects stronger margins and operating cash generation beginning in 2027.
SEC Filings
Gregory S. Meyer backs Epic Pass but wants automated dining, faster rental pickup and a plan for debt due in 2030.
SEC Filings
The notes pay 10% annual interest, while an ownership cap blocks conversion of the funds' preferred stock.
SEC Filings
Profit rose 59%, and Cisco raised its fiscal 2027 AI infrastructure revenue expectation for large cloud providers to $9 billion.
SEC Filings
Lower spending narrowed the quarterly loss, but NeuroPace now expects a larger adjusted EBITDA loss for the year.
SEC Filings
The financing combines bonds, delayed-draw loan borrowings and existing cash, with bond repayment due in 2033 and 2036.
SEC Filings
The previously priced share offering would help repay loans under a facility carrying an 11.5% interest rate as of September 30.
SEC Filings
The TimberStrand expansion would add about 24% to engineered-wood capacity as the company reports softer single-family construction.
SEC Filings
Overall restructuring charges fell, but lease costs rose and Starbucks still owed $336.2 million under its restructuring plans.
SEC Filings
Patient dosing has begun for CR-002, with initial results expected in the second half of 2027.
SEC Filings
The largest bond series initially pays 5.732%, before switching to a floating rate in November 2033.